Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53

International Journal of Cancer

Volumn 73, Issue 1, 1997, Pages 38-41

  Bukholm, Ida K ^a   Nesland, Jahn M ^a,c   Karesen, Rolf ^a   Jacobsen, Ulf ^b   Borresen Dale, Anne Lise ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Buskerud Central Hospital   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN;

EID: 0030766494     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970926)73:1<38::AID-IJC7>3.0.CO;2-2     Document Type: Article

References (27)

1. BAFFY, G., MIYASHITA, T., WILLIAMSON, J.R. and REED, J.C., Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced bcl-2 oncoprotein production. J. biol. Chem., 25, 6511-6519 (1997).
2. BEAHR, O.H., HENSON, D.E., MUTTER, R.V.P, and MYERS, M.H., Manual for staging of cancer, 3rd ed., p. 145. J.P. Lippincott. Philadelphia (1988).
3. BUKHOLM, I., NESLAND, J.M., KÄRESEN, R., JACOBSEN, U. and BORRESEN, A.L., Relationship between abnormal p53 protein and failure to express p21. J. Pathol. 181, 140-145 (1997).
4. CAFFO, O., DOGLIONI. C., VEONESE, S., BONZANINI, M., MARCHETTI, A., BUTTITTA, F., FINA. P., LEEK. R., MORELLI. L., PALMA. P.D., HARRIS, A.L. and BARBARESCHI, M., Prognostic value of p21 WAF1 and p53 expression in breast carcinoma: an immunohistochemical study in 216 patients with long-term follow-up. Clin. Cancer Res., 2, 1591-1599 (1996).
5. CHEN, C.Y. and FALLER, D.V., Phosphorylation of bcl-2 protein and association with p21ras in ras-induced apoptosis. J. biol. Chem., 271, 2376-2379 (1996).
6. CLARKE, A.R., PURDIE, C.A., HARRISON, D.J., MORRIS, R.G., BIRD, C.C., HOOPER. M.L. and WYLLIE. A.H., Thymocyte apoptosis induced by p53-dependent and independent pathways [see comments]. Nature (Lond.), 362, 849-852 (1993).
7. CROSS, M. and DEXTER, T.M., Growth factors in development, transformation and tumorigenesis [Review], Cell, 64, 271-280 (1991).
8. DOGLIONI, C., Tos, A.P.D., LAURINO, L., CHIARELLI. C., BARBARESCHI, M. and VIALE, G., The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen-receptor status. Vmiittws Archiv., 424, 47-51 (1994).
9. ELSTON, C.W. and ELLIS. I.O., Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology, 19, 403-410 (1991).
10. GASPARINI, G., BARBARESCHI, M., DOGLIONI, C., PALMA, P.D., MAURINI, FA., BORACCHI, P., BEVILACQUA, P., CAFFO, O., MORELLI. L., VERDERIO, P., PEZZELLA, F. and HARRIS, A.L., Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin. Cancer Res., 1, 189-198 (1195).
11. GUJULUVA, C.N., BAEK, J.H., SHIN. K.H,. CHERRICK, H.M. and PARK, N.H., Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes. Oncogene, 9, 1819-1827 (1994).
12. 1cyclindependent kinases. Cell. 75, 805-816 (1993).
13. HELLEMANS, P., VAN DAM, P.A., WEYLER, J., VAN OOSTEROM. A.T., BUYTAERT, P. and VAN MARCK. E., Prognostic value of bcl-2 expression in invasive breast cancer. Brif. J. Cancer, 72, 354-360 (1995).
14. HOCKENBERY, D., NUNEZ, G., MILLIMAN, C., SCHREIBER, R.D. and KORS- MEYER, S.J., bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348, 334-336 (1990).
15. HSU, S.M., RAINE, L. and FANGER, H., A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Amer. J. clin. Pathol., 75, 734-738 (1981).
16. JAKUS, J. and YEUDALL, A.W., Growth-inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell-cycle control in squamouscarcinoma cells, Oncogene. 12, 2369-2376 (1996).
17. JOENSUU, H., PYLKKANEN, L. and TOIKKANEN, S., bcl-2 protein expression and long-term survival in breast cancer. Am. J. Pathol., 145, 1191-1198 (1994).
18. MICHIELI. P., CHEDID. M., LIN. D., PIERCE. J.H., MERCER. W.E. and GIVOL, D., Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54, 3391-3395 (1994).
19. MINN. A.J., VELEZ. P., SCHENDEL. S.L., LING. H., MUCHMORE, S.W., FESIK, S.W., FILL. M. and THOMPSON, C.B., bcl-XL forms an ion channel in synthetic lipid membranes. Nature (Lontl.), 385, 353-357 (1997).
20. 2 arrest induced by nitrogen mustard. Proc. nat. Acatd. Sci. (Wash.), 91, 9480-9484 (1994).
21. RAFF, M.C., Social controls on cell survival and cell death. [Review], Nature (Lond.), 356, 397-400 (1992).
22. RAVI, D., NALINAKUMARI, K.R., RAJARAM. R.S., NAIR KRISHNAN. M. and PILLAI RADHAKRISHNA, M., Expression of programmed-cell-death-regulatory p53 and bcl-2 proteins in oral lesion. Cancer Lett., 105, 139-146 (1996).
23. SENTMAN, C.L., SHUTTER, J.R., HOCKENBERY, D., KANAGAWA, O. and KOKSMEYER, S.J., bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymoeytes. Cell. 67, 879-888 (1991).
24. SIERRA, A., LLOVERAS. B., CASTELLSAGUE, X., MORENO, L., GARCIA-RAMIREZ, M. and FABKA. A., bcl-2 expression is associated with lymph-node metastasis in human ductal breast carcinoma. Int. J. Cancer, 60, 54-60 (1995).
25. SMITH, M.L. and FORNACE, A.J., JR., Genomic instability and the role of p53 mutations in cancer cells. [Review J. Curr. Opin. Oncol., 7, 69-75 (1995).
26. SIRASSER, A., HARRIS, A.W. and CORY. S., bcl-2 transgene inhibits T-cell death and perturbs thymic self-censorship. Cell. 67, 889-899 (1991).
27. UPADHYAY, S., LI, G., LIU, H., CHEN, Y.Q., SARKAR, F.H. and KIM. H.R., bcl-2 suppresses expression of p21 WAF1/CIP1 in breast epithelial cells. Cancer Res., 55, 4520-4524 (1995).